Determining Childhood Blood Lead Level Screening Compliance Among Physicians
Amanda Haboush-Deloye1, Erika R Marquez2, Shawn L Gerstenberger3
1Nevada Institute for Children's Research and Policy, University of Nevada, Las Vegas, 4505 Maryland, Parkway, Box 453064, Las Vegas, NV, 89154-3030, USA. amanda.haboush@unlv.edu.
Insights
Physician non-compliance with lead screening guidelines and low parental adherence to blood lead level (BLL) testing orders hinder childhood lead poisoning prevention. Addressing these barriers is crucial for increasing testing rates in children.
Area of Science:
- Environmental Health
- Pediatrics
- Public Health Policy
Background:
- Childhood lead poisoning remains a significant public health concern despite prevention programs.
- Existing programs have improved screening rates, yet gaps persist, particularly for children under six.
- Identifying barriers to blood lead level (BLL) testing is essential for effective prevention strategies.
Purpose of the Study:
- To identify barriers to childhood blood lead level (BLL) testing.
- To develop strategies for increasing BLL testing rates in children.
- To assess physician adherence to CDC guidelines and parental compliance with BLL testing orders.
Main Methods:
- A survey of Clark County physicians regarding BLL testing practices and adherence to CDC guidelines.
- In-person interviews with physicians reporting high parental compliance to identify best practices.
- Analysis of physician-reported data on testing adherence and parental compliance.
Main Results:
- 48% of surveyed physicians did not follow CDC guidelines for BLL testing.
- 60% of physicians reported over 80% parental compliance with recommended BLL testing.
- Key barriers identified include cost, lack of insurance, absence of symptoms, and inadequate parental adherence.
Conclusions:
- Physician non-compliance with screening recommendations and inadequate parental adherence to testing orders are primary barriers to childhood lead screening.
- Addressing these barriers is critical to increasing testing rates and reducing the risk of childhood lead poisoning.
- Strategies targeting physician practice and parental engagement are needed to improve BLL testing coverage.
Abstract:
Childhood Lead Poisoning Prevention Programs throughout the U.S. have addressed childhood lead poisoning by implementing primary and secondary prevention efforts. While many programs have helped increase screening rates, in some states children under the age of six still have not been tested for lead. This study aims to identify the barriers to childhood blood lead testing and develop a strategy to increase the number of children tested. Clark County physicians who work with children six and under were surveyed about blood lead level (BLL) testing practices, particularly, adherence to Centers for Disease Control and Prevention (CDC) guidelines, and parental compliance with orders to have their children tested to determine their blood lead levels. In addition, select in-person interviews were conducted with physicians who reported high parental compliance to identify best practices and barriers. Of the 77 physicians that provided data, 48% indicated they did not follow CDC guideline compared to 52% who follow guidelines. 18 of the 30 (or 60%) physicians reported more than 80% of parents complied with doctor recommended BLL testing. Twelve physicians identified cost, lack of insurance, and absence of symptomology as persistent barriers to lead screening. This study identified barriers to childhood lead screening including inadequate parental adherence to physician-ordered screenings and physician non-compliance with screening recommendations are two primary contributors. Addressing these issues could increase screening in children and reduce the risk of lead poisoning.
Related Concept Videos
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Pre-Procedural Guidelines for Assessing Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Bioavailability Study Design: Healthy Subjects Versus Patients
Assessing Blood pressure in the Leg
Preparation:


